Anti-EFNA5/ AF1/ EFL5 monoclonal antibody
Anti-EFNA5/ AF1/ EFL5 antibody for FACS & in-vivo assay
Go to EFNA5/EFNA5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0396-Ab-1/ GM-Tg-hg-MP0396-Ab-2 | Anti-Human EFNA5 monoclonal antibody | Human |
GM-Tg-rg-MP0396-Ab-1/ GM-Tg-rg-MP0396-Ab-2 | Anti-Rat EFNA5 monoclonal antibody | Rat |
GM-Tg-mg-MP0396-Ab-1/ GM-Tg-mg-MP0396-Ab-2 | Anti-Mouse EFNA5 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0396-Ab-1/ GM-Tg-cynog-MP0396-Ab-2 | Anti-Cynomolgus/ Rhesus macaque EFNA5 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0396-Ab-1/ GM-Tg-felg-MP0396-Ab-2 | Anti-Feline EFNA5 monoclonal antibody | Feline |
GM-Tg-cang-MP0396-Ab-1/ GM-Tg-cang-MP0396-Ab-2 | Anti-Canine EFNA5 monoclonal antibody | Canine |
GM-Tg-bovg-MP0396-Ab-1/ GM-Tg-bovg-MP0396-Ab-2 | Anti-Bovine EFNA5 monoclonal antibody | Bovine |
GM-Tg-equg-MP0396-Ab-1/ GM-Tg-equg-MP0396-Ab-2 | Anti-Equine EFNA5 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0396-Ab-1/ GM-Tg-hg-MP0396-Ab-2; GM-Tg-rg-MP0396-Ab-1/ GM-Tg-rg-MP0396-Ab-2; GM-Tg-mg-MP0396-Ab-1/ GM-Tg-mg-MP0396-Ab-2; GM-Tg-cynog-MP0396-Ab-1/ GM-Tg-cynog-MP0396-Ab-2; GM-Tg-felg-MP0396-Ab-1/ GM-Tg-felg-MP0396-Ab-2; GM-Tg-cang-MP0396-Ab-1/ GM-Tg-cang-MP0396-Ab-2; GM-Tg-bovg-MP0396-Ab-1/ GM-Tg-bovg-MP0396-Ab-2; GM-Tg-equg-MP0396-Ab-1/ GM-Tg-equg-MP0396-Ab-2 |
Products Name | Anti-EFNA5 monoclonal antibody |
Format | mab |
Target Name | EFNA5 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-EFNA5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species EFNA5/ AF1/ EFL5 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLPm004704 | mouse Efna5 Lentivirus plasmid |
ORF Viral Vector | vGMLPm004704 | mouse Efna5 Lentivirus particle |
Target information
Target ID | GM-MP0396 |
Target Name | EFNA5 |
Gene ID | 1946,13640,116683,704351,608458,101085951,616742,100073202 |
Gene Symbol and Synonyms | AF1,AL-1,EFL-5,EFL5,EFNA5,Ephrin-A5,Epl7,EPLG7,GLC1M,LERK-7,LERK7,RAGS |
Uniprot Accession | P52803,P97605 |
Uniprot Entry Name | EFNA5_HUMAN,EFNA5_RAT |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Breast Cancer |
Gene Ensembl | ENSG00000184349 |
Target Classification | N/A |
The target: EFNA5, gene name: EFNA5, also named as AF1, EFL5, EPLG7, GLC1M, LERK7, RAGS. Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.